<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta name="description" content="Investor information for Spoke Medical - Learn about our business model, growth strategy, and investment opportunity in the £220M+ ear care market.">
  <title>Investors | Spoke Medical</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Bricolage+Grotesque:wght@400;600;700&family=Barlow:wght@300;400;500;600;700&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="css/styles.css">
</head>
<body>
  <!-- Header -->
  <header class="header" role="banner">
    <div class="container">
      <div class="header-content">
        <div class="logo">
          <a href="index.html" aria-label="Spoke Medical Home">
            <img src="images/logo.svg" alt="Spoke Medical Logo" style="height: 80px;">
          </a>
        </div>
        <nav class="main-nav" role="navigation" aria-label="Main Navigation">
          <button class="mobile-menu-toggle" aria-label="Toggle Menu" aria-expanded="false">
            <span></span>
            <span></span>
            <span></span>
          </button>
          <ul>
            <li><a href="index.html">Home</a></li>
            <li><a href="about.html">About</a></li>
            <li><a href="zephyr.html">Zephyr</a></li>
            <li><a href="market.html">Market</a></li>
            <li><a href="investors.html" class="active">Investors</a></li>
            <li><a href="contact.html">Contact</a></li>
          </ul>
        </nav>
      </div>
    </div>
  </header>

  <!-- Hero Section -->
  <section class="hero-section">
    <div class="container">
      <h1>Investor Information</h1>
      <p class="hero-subtitle">A compelling opportunity in medical device innovation</p>
    </div>
  </section>

  <!-- Investment Highlights Section -->
  <section class="section">
    <div class="container">
      <div class="section-header text-center">
        <h2 class="section-title">Investment Highlights</h2>
        <p class="section-subtitle">Key reasons to invest in Spoke Medical</p>
      </div>

      <div class="feature-grid">
        <div class="feature-card">
          <div class="feature-icon">
            <img src="images/icons/icon-market.svg" alt="Market icon" loading="lazy">
          </div>
          <h3 class="feature-title">£220M+ Market</h3>
          <p>Addressing a substantial and growing UK ear care market with 4 million annual procedures and clear international expansion potential.</p>
        </div>
        <div class="feature-card">
          <div class="feature-icon">
            <img src="images/icons/icon-innovation.svg" alt="Innovation icon" loading="lazy">
          </div>
          <h3 class="feature-title">Patented Innovation</h3>
          <p>First innovation in microsuction technology in over 50 years, with strong IP protection and regulatory approvals creating barriers to entry.</p>
        </div>
        <div class="feature-card">
          <div class="feature-icon">
            <img src="images/icons/icon-validation.svg" alt="Validation icon" loading="lazy">
          </div>
          <h3 class="feature-title">Clinical Validation</h3>
          <p>Independently validated by University of Salford Acoustics Calibration Laboratory, with compelling evidence of clinical benefits and safety improvements.</p>
        </div>
        <div class="feature-card">
          <div class="feature-icon">
            <img src="images/icons/icon-revenue.svg" alt="Revenue icon" loading="lazy">
          </div>
          <h3 class="feature-title">Recurring Revenue</h3>
          <p>Premium product with recurring revenue from consumables, creating a sustainable business model with strong margins and customer retention.</p>
        </div>
      </div>

      <div class="investor-highlight mt-5">
        <h3>Regulatory Catalyst</h3>
        <p>ENT UK's 2024 clinical guidance on microsuction highlights significant risks with traditional equipment, creating an immediate market need for Zephyr's safer technology. This regulatory catalyst is driving accelerated adoption across all market segments.</p>
      </div>
    </div>
  </section>

  <!-- Business Model Section -->
  <section class="section section-alt">
    <div class="container">
      <div class="section-header text-center">
        <h2 class="section-title">Business Model</h2>
        <p class="section-subtitle">A sustainable approach to growth and profitability</p>
      </div>

      <div class="product-showcase">
        <div class="product-image">
          <img src="images/business-model.jpg" alt="Spoke Medical business model illustration showing revenue streams" loading="lazy">
        </div>
        <div class="product-content">
          <h3>Multi-Stream Revenue Model</h3>
          <div class="product-features">
            <div class="product-feature">
              <span class="feature-check">✓</span>
              <div>
                <strong>Initial Equipment Sales</strong>
                <p>Premium pricing for Zephyr base units with volume incentives for larger deployments</p>
              </div>
            </div>
            <div class="product-feature">
              <span class="feature-check">✓</span>
              <div>
                <strong>Recurring Consumables</strong>
                <p>Ongoing revenue from proprietary single-use tips and accessories</p>
              </div>
            </div>
            <div class="product-feature">
              <span class="feature-check">✓</span>
              <div>
                <strong>Service Contracts</strong>
                <p>Annual maintenance and support agreements for institutional customers</p>
              </div>
            </div>
            <div class="product-feature">
              <span class="feature-check">✓</span>
              <div>
                <strong>Training Programs</strong>
                <p>Certified training for clinical staff to optimize device usage and outcomes</p>
              </div>
            </div>
          </div>
        </div>
      </div>

      <div class="financial-data mt-5">
        <div class="financial-metric">
          <div class="metric-value">30-40%</div>
          <div class="metric-label">Target Gross Margins</div>
        </div>
        <div class="financial-metric">
          <div class="metric-value">60%</div>
          <div class="metric-label">Revenue from Recurring Sources</div>
        </div>
        <div class="financial-metric">
          <div class="metric-value">£1,200-1,800</div>
          <div class="metric-label">Annual Consumables Revenue Per Device</div>
        </div>
        <div class="financial-metric">
          <div class="metric-value">3-5 Years</div>
          <div class="metric-label">Target Payback Period</div>
        </div>
      </div>
    </div>
  </section>

  <!-- Growth Strategy Section -->
  <section class="section">
    <div class="container">
      <div class="section-header text-center">
        <h2 class="section-title">Growth Strategy</h2>
        <p class="section-subtitle">Our roadmap for sustainable expansion</p>
      </div>

      <div class="tabs-container">
        <div class="tabs-nav" role="tablist">
          <button id="tab-phase1" class="tab-btn active" role="tab" aria-selected="true" aria-controls="panel-phase1" onclick="showTab('phase1', event)">Phase 1: UK Market</button>
          <button id="tab-phase2" class="tab-btn" role="tab" aria-selected="false" aria-controls="panel-phase2" onclick="showTab('phase2', event)">Phase 2: European Expansion</button>
          <button id="tab-phase3" class="tab-btn" role="tab" aria-selected="false" aria-controls="panel-phase3" onclick="showTab('phase3', event)">Phase 3: Global Growth</button>
        </div>

        <div id="panel-phase1" class="tab-pane active" role="tabpanel" aria-labelledby="tab-phase1">
          <div class="investor-highlight">
            <h3>UK Market Penetration (2025-2026)</h3>
            <ul>
              <li><strong>Target:</strong> 15-20% market share within 18 months</li>
              <li><strong>Focus:</strong> Private audiology chains and independent clinics</li>
              <li><strong>Strategy:</strong> Direct sales team and strategic distribution partnerships</li>
              <li><strong>Key Activities:</strong>
                <ul>
                  <li>Expand sales team to cover all UK regions</li>
                  <li>Establish key opinion leader network</li>
                  <li>Implement demonstration program for major clinics</li>
                  <li>Develop case studies and ROI calculators</li>
                </ul>
              </li>
            </ul>
          </div>
        </div>

        <div id="panel-phase2" class="tab-pane" role="tabpanel" aria-labelledby="tab-phase2">
          <div class="investor-highlight">
            <h3>European Expansion (2026-2027)</h3>
            <ul>
              <li><strong>Target:</strong> Germany, France, Benelux, Nordics</li>
              <li><strong>Focus:</strong> Leverage existing CE Mark certification</li>
              <li><strong>Strategy:</strong> Country-specific distribution partners with local expertise</li>
              <li><strong>Key Activities:</strong>
                <ul>
                  <li>Establish European headquarters</li>
                  <li>Adapt marketing materials for local markets</li>
                  <li>Participate in key European ENT and audiology conferences</li>
                  <li>Build relationships with European medical associations</li>
                </ul>
              </li>
            </ul>
          </div>
        </div>

        <div id="panel-phase3" class="tab-pane" role="tabpanel" aria-labelledby="tab-phase3">
          <div class="investor-highlight">
            <h3>Global Growth (2027-2029)</h3>
            <ul>
              <li><strong>Target:</strong> North America, Australia, Asia</li>
              <li><strong>Focus:</strong> FDA approval and international regulatory compliance</li>
              <li><strong>Strategy:</strong> Strategic partnerships with established medical device distributors</li>
              <li><strong>Key Activities:</strong>
                <ul>
                  <li>Complete FDA approval process</li>
                  <li>Establish manufacturing partnerships for scale</li>
                  <li>Develop next-generation product line</li>
                  <li>Explore adjacent market opportunities</li>
                </ul>
              </li>
            </ul>
          </div>
        </div>
      </div>

      <div class="market-chart mt-5">
        <img src="images/growth-projection-chart.jpg" alt="Spoke Medical growth projection chart showing revenue and market share targets" loading="lazy">
      </div>
    </div>
  </section>

  <!-- IP & Regulatory Position Section -->
  <section class="section section-alt">
    <div class="container">
      <div class="section-header text-center">
        <h2 class="section-title">IP & Regulatory Position</h2>
        <p class="section-subtitle">Strong protection and compliance</p>
      </div>

      <div class="clinical-data">
        <h3>Intellectual Property</h3>
        <ul>
          <li><strong>Patents:</strong> Multiple patents filed and granted covering:
            <ul>
              <li>Noise reduction technology</li>
              <li>Anti-block mechanism</li>
              <li>Precision airflow control system</li>
              <li>Ergonomic design elements</li>
            </ul>
          </li>
          <li><strong>Trademarks:</strong> "Zephyr" and "Spoke Medical" registered in key markets</li>
          <li><strong>Trade Secrets:</strong> Proprietary manufacturing processes and formulations</li>
          <li><strong>Copyright:</strong> Software, documentation, and training materials</li>
        </ul>
      </div>

      <div class="clinical-data mt-4">
        <h3>Regulatory Approvals</h3>
        <ul>
          <li><strong>CE Mark:</strong> Obtained for European market access</li>
          <li><strong>UKCA:</strong> Certified for post-Brexit UK market</li>
          <li><strong>ISO 13485:</strong> Manufacturing quality management system</li>
          <li><strong>Class IIa:</strong> Medical device classification</li>
          <li><strong>FDA:</strong> Pre-submission process initiated</li>
        </ul>
      </div>

      <div class="investor-highlight mt-4">
        <h3>Competitive Barriers</h3>
        <p>Our comprehensive IP strategy and regulatory position create significant barriers to entry for potential competitors. The combination of patents, regulatory approvals, and first-mover advantage provides Spoke Medical with a protected market position and sustainable competitive advantage.</p>
      </div>
    </div>
  </section>

  <!-- Financial Projections Section -->
  <section class="section">
    <div class="container">
      <div class="section-header text-center">
        <h2 class="section-title">Financial Projections</h2>
        <p class="section-subtitle">Our path to profitability</p>
      </div>

      <div class="market-chart">
        <img src="images/financial-projections-chart.jpg" alt="Spoke Medical financial projections chart showing revenue, costs, and profitability" loading="lazy">
      </div>

      <div class="investor-highlight mt-4">
        <h3>Key Financial Metrics</h3>
        <ul>
          <li><strong>Year 1 Revenue Target:</strong> £1.2M</li>
          <li><strong>Year 3 Revenue Target:</strong> £5.8M</li>
          <li><strong>Year 5 Revenue Target:</strong> £12.5M</li>
          <li><strong>Gross Margin:</strong> 30-40%</li>
          <li><strong>Projected Break-Even:</strong> Q4 2026</li>
          <li><strong>Target EBITDA (Year 5):</strong> 22-25%</li>
        </ul>
      </div>

      <div class="investor-highlight mt-4">
        <h3>Use of Funds</h3>
        <ul>
          <li><strong>Sales & Marketing (40%):</strong> Expand UK sales team, develop marketing materials, implement demonstration program</li>
          <li><strong>Manufacturing (25%):</strong> Scale production capacity, optimize supply chain, reduce COGS</li>
          <li><strong>R&D (20%):</strong> Develop next-generation products, expand IP portfolio</li>
          <li><strong>Regulatory & Compliance (10%):</strong> Obtain international approvals, maintain quality systems</li>
          <li><strong>Working Capital (5%):</strong> Support inventory and accounts receivable growth</li>
        </ul>
      </div>
    </div>
  </section>

  <!-- Team Section -->
  <section class="section section-alt">
    <div class="container">
      <div class="section-header text-center">
        <h2 class="section-title">Leadership Team</h2>
        <p class="section-subtitle">Experienced professionals driving our success</p>
      </div>

      <div class="team-grid">
        <div class="team-member">
          <img src="images/patrick-axon.jpg" alt="Patrick Axon, Medical Director" class="team-image" loading="lazy">
          <div class="team-info">
            <h3 class="team-name">Patrick Axon</h3>
            <div class="team-role">Medical Director</div>
            <p>Consultant ENT Surgeon with over 20 years of clinical experience. Former president of the British Society of Otology and advisor to ENT UK.</p>
          </div>
        </div>
        <div class="team-member">
          <img src="images/neil-donnelly.jpg" alt="Neil Donnelly, CEO" class="team-image" loading="lazy">
          <div class="team-info">
            <h3 class="team-name">Neil Donnelly</h3>
            <div class="team-role">Chief Executive Officer</div>
            <p>Serial entrepreneur with a track record of building successful medical device companies. Previously founded and led MedTech innovations that achieved significant market penetration.</p>
          </div>
        </div>
        <div class="team-member">
          <img src="images/team-placeholder.jpg" alt="Sarah Chen, CTO" class="team-image" loading="lazy">
          <div class="team-info">
            <h3 class="team-name">Sarah Chen, PhD</h3>
            <div class="team-role">Chief Technology Officer</div>
            <p>Biomedical engineer with expertise in medical device development and regulatory approval pathways. Previously led R&D teams at major medical technology companies.</p>
          </div>
        </div>
        <div class="team-member">
          <img src="images/team-placeholder.jpg" alt="James Wilson, CFO" class="team-image" loading="lazy">
          <div class="team-info">
            <h3 class="team-name">James Wilson</h3>
            <div class="team-role">Chief Financial Officer</div>
            <p>Financial strategist with extensive experience in healthcare investment and MedTech scaling. Previously led successful funding rounds for multiple healthcare startups.</p>
          </div>
        </div>
      </div>

      <div class="investor-highlight mt-5">
        <h3>Advisory Board</h3>
        <ul>
          <li><strong>Professor David Thompson</strong> - Leading ENT specialist and researcher</li>
          <li><strong>Dr. Elizabeth Chen</strong> - Former regulatory affairs director at major medical device company</li>
          <li><strong>Michael Roberts</strong> - Healthcare investment specialist with 25+ years experience</li>
          <li><strong>Dr. Samantha Patel</strong> - Audiology practice owner and clinical innovator</li>
        </ul>
      </div>
    </div>
  </section>

  <!-- Investment Opportunity Section -->
  <section class="section">
    <div class="container">
      <div class="section-header text-center">
        <h2 class="section-title">Investment Opportunity</h2>
        <p class="section-subtitle">Join us in revolutionizing ear care</p>
      </div>

      <div class="investor-highlight">
        <h3>Current Funding Round</h3>
        <ul>
          <li><strong>Seeking:</strong> £2.5M in growth capital</li>
          <li><strong>Use of Funds:</strong> Accelerate UK market penetration, prepare for European expansion</li>
          <li><strong>Previous Funding:</strong> £1.2M seed round (2023)</li>
          <li><strong>Current Valuation:</strong> Available upon request with signed NDA</li>
          <li><strong>Minimum Investment:</strong> £100,000</li>
        </ul>
      </div>

      <div class="investor-highlight mt-4">
        <h3>Exit Strategy</h3>
        <ul>
          <li><strong>Primary Strategy:</strong> Strategic acquisition by established medical device company (5-7 year horizon)</li>
          <li><strong>Secondary Strategy:</strong> Private equity investment for international expansion</li>
          <li><strong>Comparable Exits:</strong> Recent medical device innovations in the ENT space have achieved 5-8x revenue multiples</li>
        </ul>
      </div>

      <div class="testimonial-grid mt-5">
        <div class="testimonial-card">
          <div class="testimonial-text">
            Spoke Medical represents a compelling investment opportunity in the medical device space. The combination of patented technology, clear market need, and experienced leadership team positions the company for significant growth.
          </div>
          <div class="testimonial-author">
            <div class="author-info">
              <div class="author-name">Lead Investor</div>
              <div class="author-role">Seed Round</div>
            </div>
          </div>
        </div>
        <div class="testimonial-card">
          <div class="testimonial-text">
            The regulatory catalyst provided by ENT UK's new guidance creates an immediate market opportunity that Spoke Medical is uniquely positioned to address. Their first-mover advantage and strong IP position make this an attractive investment proposition.
          </div>
          <div class="testimonial-author">
            <div class="author-info">
              <div class="author-name">Healthcare Investment Analyst</div>
              <div class="author-role">Major Investment Firm</div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </section>

  <!-- CTA Section -->
  <section class="section cta-section">
    <div class="container">
      <div class="cta-content text-center">
        <h2>Interested in Learning More?</h2>
        <p>Contact our investor relations team to request our detailed investor deck and financial projections.</p>
        <div>
          <a href="contact.html" class="btn btn-primary">Contact Investor Relations</a>
        </div>
      </div>
    </div>
  </section>

  <!-- Footer -->
  <footer class="footer">
    <div class="container">
      <div class="footer-content">
        <div class="footer-logo">
          <h2>SPOKE MEDICAL</h2>
          <p>Redefining medical innovation</p>
        </div>
        <div class="footer-links">
          <div class="footer-nav">
            <h3>Navigation</h3>
            <ul>
              <li><a href="index.html">Home</a></li>
              <li><a href="about.html">About</a></li>
              <li><a href="zephyr.html">Zephyr</a></li>
              <li><a href="market.html">Market</a></li>
              <li><a href="investors.html">Investors</a></li>
              <li><a href="contact.html">Contact</a></li>
            </ul>
          </div>
          <div class="footer-contact">
            <h3>Contact</h3>
            <p>Email: info@spokemedical.com</p>
            <p>LinkedIn: <a href="https://www.linkedin.com/company/spokemedical/" target="_blank" rel="noopener">Spoke Medical</a></p>
            <p>Cambridge Science Park<br>Cambridge, UK</p>
          </div>
        </div>
      </div>
      <div class="footer-bottom">
        <p>&copy; 2025 Spoke Medical. All rights reserved.</p>
        <div class="footer-legal">
          <a href="#">Privacy Policy</a>
          <a href="#">Terms of Use</a>
        </div>
      </div>
    </div>
  </footer>

  <script src="js/main.js" defer></script>
</body>
</html>
